HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Richard E. Clark George J. Magovern Ignacio Y. Christlieb Stuart Boe Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clark, R. E. Articles by Boe, S. Search for Related Content PubMed PubMed Citation Articles by Clark, R. E. Articles by Boe, S.

Ann Thorac Surg 1983;36:654-663
© 1983 The Society of Thoracic Surgeons

---

Articles

Nifedipine Cardioplegia Experience: Results of a 3-Year Cooperative Clinical Study

From the Departments of Surgery, Washington University School of Medicine, St. Louis, MO, and the Allegheny General Hospital, Pittsburgh, PA

^* Address reprint requests to Dr. Clark, NHLBI, Bldg 10, Room 2N242, National Institutes of Health, Bethesda, MD 20205

Previous animal studies and a preliminary clinical trial of the addition of nifedipine to cardioplegic solution demonstrated salutary effects in terms of postischemic performance. This report examines the combined results of extended clinical trials conducted in two centers: Barnes Hospital, St. Louis, and Allegheny General Hospital, Pittsburgh. From an open-heart population of 4,777 patients, 205 highest-risk persons were selected for study. One hundred seventy of them were given nifedipine in cardioplegic solution. The remaining 35 served as controls to compare with 39 treated patients in the randomized subset of 74. Thirty-eight percent were women; the average age was 61 ± 1 year; and most were in New York Heart Association Class IV.

One-third had valve replacement, one-quarter had coronary artery bypass grafting (CABG), and 37% had valve, CABG, and other procedures in combination. Characteristically, these patients had a 50% increase in end-diastolic volumes, low cardiac indexes (1.7 ± 1 L/min/m²), and low left ventricular stroke work indexes (22 ± 2 gm-m/m²). Average cross-clamp time was 77 minutes. At Allegheny, an extracellular hyperkalemic solution was used to deliver an average dose of 407 ± 22 µg per patient. At Barnes, a low-sodium hyperkalemic solution was used; the average dose was 476 ± 22 µg. The results of hemodynamic studies in the randomized subset demonstrated approximately a twofold greater improvement in the treated group in cardiac index, stroke volume, left ventricular stroke work index, and pulmonary vascular resistance immediately after bypass. The incidence of acute low cardiac output death was 4% versus 11% in the nontreated group. The hospital survivorship for all treated patients was 84%. It is concluded that the addition of a calcium antagonist, nifedipine, reduced the incidence of acute global cardiac failure in the immediate postoperative interval.

This article has been cited by other articles:

				F. Dagenais, R. Cartier, C. Hollmann, and J. Buluran Calcium-Channel Blockers Preserve Coronary Endothelial Reactivity After Ischemia-Reperfusion Ann. Thorac. Surg., April 1, 1997; 63(4): 1050 - 1056. [Abstract] [Full Text]

				B. K. Podesser, S. Schwarzacher, W. Zwoelfer, T. M. Binder, E. Wolner, and R. Seitelberger COMPARISON OF PERIOPERATIVE MYOCARDIAL PROTECTION WITH NIFEDIPINE VERSUS NIFEDIPINE AND METOPROLOL IN PATIENTS UNDERGOING ELECTIVE CORONARY ARTERY BYPASS GRAFTING J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1461 - 1469. [Abstract] [Full Text]

				M. E. Mitchell, D. A. DeBoer, M. D. Crittenden, and R. E. Clark Nicardipine: Myocardial protection in isolated working hearts Ann. Thorac. Surg., October 1, 1992; 54(4): 712 - 716. [Abstract] [PDF]

				C. Munsch Review article : Blood cardioplegia Perfusion, October 1, 1991; 6(4): 245 - 252. [PDF]

				P. S. Brown, G. L. Parenteau, F. W. Holland, and R. E. Clark Pretreatment with nicardipine preserves ventricular function after hypothermic ischemic arrest Ann. Thorac. Surg., May 1, 1991; 51(5): 739 - 746. [Abstract] [PDF]

				F. Mori, M. Miyamoto, H. Tsuboi, H. Noda, and K. Esato Clinical trial of nicardipine cardioplegia in pediatric cardiac surgery Ann. Thorac. Surg., March 1, 1990; 49(3): 413 - 418. [Abstract] [PDF]

				R. W. Landymore, A. E. Marble, A. Trillo, G. Faulkner, M. A. MacAulay, and C. Cameron Prevention of Myocardial Electrical Activity during Ischemic Arrest with Verapamil Cardioplegia Ann. Thorac. Surg., May 1, 1987; 43(5): 534 - 538. [Abstract] [PDF]

				T. B. Ferguson Jr., L. S. Smith, P. K. Smith, R. J. Damiano, and J. L. Cox Electrical Activity in the Heart during Hyperkalemic Hypothermic Cardioplegic Arrest: Site of Origin and Relationship to Specialized Conduction Tissue Ann. Thorac. Surg., April 1, 1987; 43(4): 373 - 379. [Abstract] [PDF]

				H. B. Barner, M. T. Swartz, J. E. Devine, G. A. Williams, and D. Janosik Diltiazem as an Adjunct to Cold Blood Potassium Cardioplegia: A Clinical Assessment of Dose and Prospective Randomization Ann. Thorac. Surg., February 1, 1987; 43(2): 191 - 197. [Abstract] [PDF]

				J. W. de Jong Cardioplegia and Calcium Antagonists: A Review Ann. Thorac. Surg., November 1, 1986; 42(5): 593 - 598. [Abstract] [PDF]

				Drugs Five Years Later: Nifedipine in Myocardial Ischemia, Systemic Hypertension, and Other Cardiovascular Disorders Ann Intern Med, November 1, 1986; 105(5): 714 - 729. [Abstract] [PDF]

				S. Slogoff, A. S. Keats, D. A. Cooley, G. J. Reul, O. H. Frazier, D. A. Ott, J. M. Duncan, and J. J. Livesay Addition of Papaverine to Cardioplegia Does Not Reduce Myocardial Necrosis Ann. Thorac. Surg., July 1, 1986; 42(1): 60 - 64. [Abstract] [PDF]

				T. B. Ferguson Jr., R. J. Damiano, P. K. Smith, W. C. Buhrman, and J. L. Cox The Electrophysiological Effects of Calcium Channel Blockade During Standard Hyperkalemic Hypothermic Cardioplegic Arrest Ann. Thorac. Surg., June 1, 1986; 41(6): 622 - 629. [Abstract] [PDF]

				M. Chiavarelli, R. Chiavarelli, A. Macchiarelli, A. Carpi, and B. Marino Calcium Entry Blockers and Cardioplegia: Interaction Between Nifedipine, Potassium, and Hypothermia Ann. Thorac. Surg., May 1, 1986; 41(5): 535 - 541. [Abstract] [PDF]

				J. M. Levett, J. H. Ip, M. H. Kadowaki, C. A. Stennis, and R. B. Karp Preservation of Myocardial High-Energy Phosphates with Vagal Stimulation and Hypothermic Cardioplegia Ann. Thorac. Surg., February 1, 1986; 41(2): 150 - 154. [Abstract] [PDF]

				G. L. Hicks Jr. and J. A. DeWeese Verapamil Potassium Cardioplegia and Cardiac Conduction Ann. Thorac. Surg., April 1, 1985; 39(4): 324 - 328. [Abstract] [PDF]

				G. L. Hicks Jr., R. K. Salley, and J. A. DeWeese Calcium Channel Blockers: An Intraoperative and Postoperative Trial in Women Ann. Thorac. Surg., April 1, 1984; 37(4): 319 - 323. [Abstract] [PDF]